CR Intrinsic Investors’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-194,248
Closed -$2.2M 308
2013
Q3
$2.2M Buy
+194,248
New +$2.2M 0.07% 262